March 03, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, is reinforcing its business operations in Germany, a strategic market for the company. Implanet, which operates in Germany via its subsidiary based in Frankfurt …